Perspective Therapeutics, Inc.

CATXAMEX • USD
0.93 USD
↘ 0.02 (1.71%)🟢LIVE (AS OF 02:00 PM EST)
🟢Market: OPEN

Perspective Therapeutics, Inc. (CATX) trades at $0.93 per share. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, CATX trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Nov 13, 2026.

Open?$0.94
High?$1.02
Low?$0.91
Prev. Close?$0.94
Volume?1.5M
Avg. Volume?3.5M
VWAP?$0.96
Rel. Volume?0.42x
Bid / Ask
Bid?$0.92 × 300
Ask?$0.93 × 1.8K
Spread?$0.01
Midpoint?$0.93
Valuation & Ratios
Market Cap?113.5M
Shares Out?120.8M
Float?97.7M
Float %?85.6%
P/E Ratio?N/A
P/B Ratio?0.39
EPS?-$1.02
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
Employees
166
Market Cap
113.9M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2003-12-29
Address
2401 ELLIOTT AVENUE
SEATTLE, WA 98121
Phone: 206-676-0900
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
0
Momentum?
50
Short Sent.?
76
Piotroski F-Score?1/9Weak
Altman Z-Score?-1.29Distress
Confidence?48%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?9.19%Elevated
Short Interest?9.0M
Days to Cover?2.5
Free Float97.7M
Avg Daily Volume3.6M
Settlement Date2026-10-30
Financial Health
Current Ratio?5.18Strong
Quick Ratio?5.18Strong
Cash Ratio?1.04Strong
Debt/Equity?0.01Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.39CHEAP▾
P/S?
Peers
100
S&P
3
515.97HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.6CHEAP▾
EV/Sales?
Peers
100
S&P
3
336.61HIGH▾
Returns & Efficiency
ROE?
S&P
3
-41.7%WEAK▾
ROA?
S&P
3
-33.6%WEAK▾
Cash Flow & Enterprise
FCF?$-138841000
Enterprise Value?$74.1M
Fundamentals ratios updated end of day